 |
 | | Revenues | 21,426.0 | 13.7 | | Profits | 3,813.0 | 25.6 | | Assets | 25,616.0 | -- | | Stockholders' Equity | 14,418.0 | -- | | Industry: Pharmaceuticals |
| 1 | Pfizer | 75 | 52,921 | | 2 | Johnson & Johnson | 88 | 47,348 | | 3 | GlaxoSmithKline | 122 | 37,304 | | 4 | Novartis | 186 | 28,247 | | 5 | Roche Group | 209 | 25,166 | | 6 | Merck | 239 | 22,939 | | 7 | Bristol-Myers Squibb | 258 | 21,886 | | 8 | AstraZeneca | 267 | 21,426 | | 9 | Abbott Laboratories | 285 | 20,473 | | 10 | Sanofi-Aventis | 321 | 18,710 | | 11 | Wyeth | 346 | 17,358 | | 12 | Eli Lilly | 445 | 13,858 | From the July 25, 2005 issue | |
